North America Pidotimod Market Insights and Forecast with 5.7% CAGR (2026–2034)
According to a new report from Intel Market Research, the North America Pidotimod market was valued at USD 28 million in 2025 and is projected to reach USD 48 million by 2034, growing at a steady CAGR of 5.7% during the forecast period (2026-2034). This growth is driven by increasing respiratory infection cases, rising adoption of immunomodulators in pediatric care, and post-pandemic healthcare...
0 Commentaires 0 Parts 147 Vue 0 Aperçu